B

bristol myers squibb

Overview

Total employees38463
Departments20
Locations83

Bristol Myers Squibb (BMS) is a leading global biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative medicines for patients with serious diseases, particularly in the therapeutic areas of oncology, hematology, immunology, and cardiovascular disease. Operating in the highly competitive pharmaceutical sector, BMS distinguishes itself through a strong pipeline of novel therapies, including biologics and small molecules. Their market position is solidified by blockbuster drugs and strategic acquisitions that strengthen their portfolio and expand their global reach, making them a significant player in improving patient outcomes worldwide.

bristol myers squibb's headcount breakdown by department

DepartmentHeadCount
Administrative
915
Consulting
197
Service
193
Design
48
Education
111

The departmental structure at Bristol Myers Squibb reflects a balanced biopharmaceutical organization driven by scientific innovation and operational excellence. The significant investment in Research & Development (4,086 employees) and Medical Affairs (3,012 employees) demonstrates a strong commitment to discovering novel therapies, conducting rigorous clinical trials, and ensuring the safety and efficacy of their products. This aligns with the pharmaceutical industry's need for extensive research and adherence to stringent regulatory standards. A substantial Operations department (2,743 employees) underscores the complexity of pharmaceutical manufacturing, quality control, and global supply chain management. The presence of Sales (1,590 employees) and Technical (1,834 employees) departments is crucial for commercialization and technical support, enabling BMS to bring innovative drugs to market and provide ongoing support to healthcare professionals. Core functions such as Legal (667 employees), Finance (567 employees), and HR (380 employees) ensure robust corporate governance, financial stability, and effective talent management. The considerable size of the 'Other' department (10,044 employees) suggests a network of specialized functions, including regulatory affairs, quality assurance, and pharmacovigilance. Overall, BMS's department distribution reflects a strategy focused on scientific innovation, regulatory compliance, and efficient global operations, characteristic of a research-intensive, patient-focused pharmaceutical company.

bristol myers squibb's employees by locations

Employee Count by Country

Total: 28,393 employees

17981
United States
63.3%
1926
India
6.8%
1068
Ireland
3.8%
877
Switzerland
3.1%
730
France
2.6%
635
United Kingdom
2.2%
605
Germany
2.1%
468
Italy
1.6%
376
China
1.3%
355
Netherlands
1.3%

Bristol Myers Squibb operates with a globally distributed workforce, demonstrating a strategic approach to penetrating worldwide markets, accessing diverse talent pools, and supporting its global operations. The United States houses the largest segment of its workforce (17,981 employees), reflecting its corporate headquarters and substantial investment in domestic R&D and commercial activities. A significant presence in Europe, particularly in Ireland (1,068 employees), Switzerland (877 employees), France (730 employees), Germany (605 employees), and the United Kingdom (635 employees), underscores the strategic importance of the European market for sales, clinical research, and manufacturing capabilities. The considerable number of employees in India (1,926 employees) points to a strategic focus on leveraging skilled resources for research, development, IT support, and business process outsourcing, capitalizing on cost efficiencies and a rapidly growing talent pool. The presence of employees in a wide range of countries across Latin America, Asia (excluding India and China), and Africa suggests a tiered market entry strategy, focusing on key regional hubs while exploring partnerships for wider market reach. Overall, the geographically diverse distribution of its workforce demonstrates BMS's commitment to conducting clinical trials in diverse populations, adapting to local regulatory requirements, and effectively commercializing its products globally. This global footprint aligns with the business model of a multinational biopharmaceutical company focused on developing, manufacturing, and commercializing its products worldwide.

Want to stay ahead of bristol myers squibb's org changes?

Get alerts when hiring spikes or teams shift focus

Track changes vs. competitors

Spot warm GTM signals early

bristol myers squibb Headcount by Region & Department | Highperform AI